{"id":"W4415517288","doi":"10.51731/cjht.2025.1264","title":"Pembrolizumab (Keytruda)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Drug; Lung cancer; Chemotherapy; Stage (stratigraphy); Compassionate Use","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004891419,0.0001976547,0.0002791327,0.000648064,0.0001930859,0.0006204223,0.0002438903,0.0003105676,0.004922651],"category_scores_gemma":[0.0008338547,0.00007220055,0.0003146734,0.0005971119,0.000147881,0.0004207795,0.0002155705,0.0005280332,0.001021357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001303181,"about_ca_system_score_gemma":0.001306285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01173115,"about_ca_topic_score_gemma":0.03995679,"domain_scores_codex":[0.9997479,0.0000501565,0.0000264159,0.00003479001,0.000108969,0.00003177693],"domain_scores_gemma":[0.9997711,0.00005415036,0.00006706877,0.000007564128,0.00007569082,0.00002444025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004999108,0.00004554963,0.0004637128,0.004766069,0.0001289141,0.0001181418,0.00002648506,0.0001288519,0.003532096,0.001527805,0.02996004,0.9588024],"study_design_scores_gemma":[0.0004731744,0.000644386,0.00561406,0.004277354,0.0004184575,0.00141946,0.00004563261,0.0001150782,0.004496205,0.0005343111,0.9819463,0.00001557233],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.007608908,0.9568991,0.0007052027,0.002404487,0.0003968566,0.0001438214,0.0008489666,0.00008248465,0.03091016],"genre_scores_gemma":[0.132913,0.8376864,0.003117056,0.003396526,0.0002956653,0.0001822217,0.001218618,0.00001669648,0.02117391],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01173115,"threshold_uncertainty_score":0.02332574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02011670427731234,"score_gpt":0.3193127526401548,"score_spread":0.2991960483628425,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}